Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Assets (2020 - 2022)

Historic Return on Assets for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to 0.05%.

  • Atea Pharmaceuticals' Return on Assets rose 200.0% to 0.05% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.05%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.15% for FY2021, which is N/A changed from last year.
  • As of Q3 2022, Atea Pharmaceuticals' Return on Assets stood at 0.05%, which was up 200.0% from 0.02% recorded in Q2 2022.
  • Over the past 5 years, Atea Pharmaceuticals' Return on Assets peaked at 0.15% during Q4 2021, and registered a low of 0.01% during Q4 2020.
  • For the 3-year period, Atea Pharmaceuticals' Return on Assets averaged around 0.05%, with its median value being 0.04% (2021).
  • As far as peak fluctuations go, Atea Pharmaceuticals' Return on Assets skyrocketed by 1600bps in 2021, and later tumbled by -200bps in 2022.
  • Quarter analysis of 3 years shows Atea Pharmaceuticals' Return on Assets stood at 0.01% in 2020, then surged by 1149bps to 0.15% in 2021, then crashed by -66bps to 0.05% in 2022.
  • Its Return on Assets was 0.05% in Q3 2022, compared to 0.02% in Q2 2022 and 0.06% in Q1 2022.